Leveraging digital medication adherence technologies to enhance sustainability of European health systems: ENABLE's key recommendations
- PMID: 39697213
- PMCID: PMC11652948
- DOI: 10.1016/j.lanepe.2024.101164
Leveraging digital medication adherence technologies to enhance sustainability of European health systems: ENABLE's key recommendations
Conflict of interest statement
JFM van Boven reports being Chair of COST Action ENABLE and his institution (UMCG) has received grants and consultancy funding from companies working in the field of medication adherence. T Ágh reports funding for attending meetings of COST Action CA19132 “ENABLE” and that his institution (Syreon Research Institute) received grants from pharmaceutical industries and NGOs. I Potočnjak reports funding for attending meetings of COST Action CA19132 “ENABLE”.
References
-
- Khan R., Socha-Dietrich K. OECD Publishing; Paris: 2018. Investing in medication adherence improves health outcomes and health system efficiency: adherence to medicines for diabetes, hypertension, and hyperlipidaemia. (OECD health working papers, No. 105). - DOI
-
- Raab R., Küderle A., Zakreuskaya A., et al. Federated electronic health records for the European health data Space. Lancet Digit Health. 2023;5(11):e840–e847. - PubMed
LinkOut - more resources
Full Text Sources